Implementation of a Standardized Management Algorithm for Cannabis Hyperemesis Syndrome in a Pediatric Emergency Department.
Cannabis hyperemesis syndrome (CHS) is an increasingly common cause of pediatric emergency department (ED) visits, yet management pathways remain understudie...
Prevalence and Correlates of Symptoms of Cannabinoid Hyperemesis Syndrome in the United States.
A groundbreaking national survey reveals cannabinoid hyperemesis syndrome prevalence affects nearly 1 in 5 daily cannabis users. This first population-level study provides critical data for clinicians treating cannabis-related health issues. The findings…
Management Approaches for Cannabinoid Hyperemesis Syndrome
Hot water relief cannabinoid hyperemesis syndrome is a key diagnostic feature of this condition affecting many regular cannabis users. This clinical review outlines management strategies and the importance of recognizing symptoms. Understanding hot water…
Editorial: New York’s Cannabis-Related Toxicity Challenges
Cannabis-related toxicity is an emerging concern following New York's legalization of recreational cannabis. Rising emergency department visits and poison control calls highlight the need for updated clinical protocols. Clinicians must recognize and…
Cannabis and Digestive Health: Understanding Clinical Risks
Digestive complications cannabis use can cause are an underrecognized clinical challenge. Cannabinoid hyperemesis syndrome is a key example with cyclic vomiting symptoms. Understanding these risks is essential for proper patient counseling.
[Management of cannabinoid hyperemesis syndrome].
Cannabinoid hyperemesis syndrome (CHS) is a condition that affects approximately one-third of cannabis users. Symptoms include recurrent episodes of vomiting...
What Works—and What Doesn’t—When CVS and CHS Attacks Strike at Home or in the ER
More research is needed to develop evidence-based, individualized abortive treatment plans, as well as to determine whether the abortive treatment for CVS requires a fundamentally different approach than for CHS.
Expert Guidance on Treating Cyclic Vomiting and Cannabis Hyperemesis Episodes at Home and in the ER
Acute abortive treatment cyclic vomiting syndrome is crucial for managing episodes early. Patients often experience a prodrome phase, allowing timely intervention. Effective abortive therapies can reduce episode severity and emergency visits.
Treating Cyclic Vomiting and Cannabinoid Hyperemesis: What the Evidence (and Experts) Currently Support
More research is needed to develop evidence-based, individualized abortive treatment plans, as well as to determine whether the abortive treatment for CVS requires a fundamentally different approach than for CHS.
Managing Cyclic Vomiting and Cannabis Hyperemesis Attacks: What the Evidence Says About Home and ER Treatment
Abortive therapy cyclic vomiting syndrome is critical for managing CVS and CHS attacks effectively. Early intervention during the prodrome phase can reduce episode severity. This approach supports home and emergency department treatment strategies.
